tert-butyl N-(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;tert-butyl N-(5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl)carbamate;tert-butyl N-([1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;ethyl N-(pyrazin-2-ylcarbamothioyl)carbamate;7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-amine;[4-[1-methyl-5-[(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)amino]-6-oxo-3-pyridinyl]-2-(1-oxo-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-2-yl)-3-pyridinyl]methyl acetate;[1,2,4]triazolo[1,5-a]pyrazin-2-amine

C82H111N37O12S — CID 157422233

IUPACtert-butyl N-(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;tert-butyl N-(5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl)carbamate;tert-butyl N-([1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;ethyl N-(pyrazin-2-ylcarbamothioyl)carbamate;7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-amine;[4-[1-methyl-5-[(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)amino]-6-oxo-3-pyridinyl]-2-(1-oxo-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-2-yl)-3-pyridinyl]methyl acetate;[1,2,4]triazolo[1,5-a]pyrazin-2-amine
SMILESCC(=O)OCc1c(-c2cc(Nc3nc4n(n3)CCN(C)C4)c(=O)n(C)c2)ccnc1N1CCn2c(cc3c2CCCC3)C1=O.CC(C)(C)OC(=O)Nc1nc2cnccn2n1.CC(C)(C)OC(=O)Nc1nc2n(n1)CCCC2.CCOC(=O)NC(=S)Nc1cnccn1.CN1CCn2nc(N)nc2C1.CN1CCn2nc(NC(=O)OC(C)(C)C)nc2C1.Nc1nc2cnccn2n1
InChIInChI=1S/C31H35N9O4.C11H19N5O2.C11H18N4O2.C10H13N5O2.C8H10N4O2S.C6H11N5.C5H5N5/c1-19(41)44-18-23-22(8-9-32-28(23)39-12-11-38-25-7-5-4-6-20(25)15-26(38)30(39)43)21-14-24(29(42)37(3)16-21)33-31-34-27-17-36(2)10-13-40(27)35-31;1-11(2,3)18-10(17)13-9-12-8-7-15(4)5-6-16(8)14-9;1-11(2,3)17-10(16)13-9-12-8-6-4-5-7-15(8)14-9;1-10(2,3)17-9(16)13-8-12-7-6-11-4-5-15(7)14-8;1-2-14-8(13)12-7(15)11-6-5-9-3-4-10-6;1-10-2-3-11-5(4-10)8-6(7)9-11;6-5-8-4-3-7-1-2-10(4)9-5/h8-9,14-16H,4-7,10-13,17-18H2,1-3H3,(H,33,35);5-7H2,1-4H3,(H,13,14,17);4-7H2,1-3H3,(H,13,14,16);4-6H,1-3H3,(H,13,14,16);3-5H,2H2,1H3,(H2,10,11,12,13,15);2-4H2,1H3,(H2,7,9);1-3H,(H2,6,9)
InChIKeyBPNVHCTZEYZZTG-UHFFFAOYSA-N
MW1839.10 g/mol
LogP7.07
Rot. Bonds11

About tert-butyl N-(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;tert-butyl N-(5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl)carbamate;tert-butyl N-([1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;ethyl N-(pyrazin-2-ylcarbamothioyl)carbamate;7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-amine;[4-[1-methyl-5-[(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)amino]-6-oxo-3-pyridinyl]-2-(1-oxo-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-2-yl)-3-pyridinyl]methyl acetate;[1,2,4]triazolo[1,5-a]pyrazin-2-amine

tert-butyl N-(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;tert-butyl N-(5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl)carbamate;tert-butyl N-([1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;ethyl N-(pyrazin-2-ylcarbamothioyl)carbamate;7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-amine;[4-[1-methyl-5-[(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)amino]-6-oxo-3-pyridinyl]-2-(1-oxo-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-2-yl)-3-pyridinyl]methyl acetate;[1,2,4]triazolo[1,5-a]pyrazin-2-amine (PubChem CID 157422233) has the molecular formula C82H111N37O12S and a molecular weight of 1839.10 g/mol. Its IUPAC name is tert-butyl N-(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;tert-butyl N-(5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl)carbamate;tert-butyl N-([1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;ethyl N-(pyrazin-2-ylcarbamothioyl)carbamate;7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-amine;[4-[1-methyl-5-[(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)amino]-6-oxo-3-pyridinyl]-2-(1-oxo-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-2-yl)-3-pyridinyl]methyl acetate;[1,2,4]triazolo[1,5-a]pyrazin-2-amine.

Molecular Properties

Compound Nametert-butyl N-(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;tert-butyl N-(5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl)carbamate;tert-butyl N-([1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;ethyl N-(pyrazin-2-ylcarbamothioyl)carbamate;7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-amine;[4-[1-methyl-5-[(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)amino]-6-oxo-3-pyridinyl]-2-(1-oxo-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-2-yl)-3-pyridinyl]methyl acetate;[1,2,4]triazolo[1,5-a]pyrazin-2-amine
PubChem CID157422233
Molecular FormulaC82H111N37O12S
Molecular Weight1839.10 g/mol
Exact Mass1837.89
IUPAC Nametert-butyl N-(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;tert-butyl N-(5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl)carbamate;tert-butyl N-([1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;ethyl N-(pyrazin-2-ylcarbamothioyl)carbamate;7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-amine;[4-[1-methyl-5-[(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)amino]-6-oxo-3-pyridinyl]-2-(1-oxo-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-2-yl)-3-pyridinyl]methyl acetate;[1,2,4]triazolo[1,5-a]pyrazin-2-amine
SMILESCC(=O)OCc1c(-c2cc(Nc3nc4n(n3)CCN(C)C4)c(=O)n(C)c2)ccnc1N1CCn2c(cc3c2CCCC3)C1=O.CC(C)(C)OC(=O)Nc1nc2cnccn2n1.CC(C)(C)OC(=O)Nc1nc2n(n1)CCCC2.CCOC(=O)NC(=S)Nc1cnccn1.CN1CCn2nc(N)nc2C1.CN1CCn2nc(NC(=O)OC(C)(C)C)nc2C1.Nc1nc2cnccn2n1
InChIInChI=1S/C31H35N9O4.C11H19N5O2.C11H18N4O2.C10H13N5O2.C8H10N4O2S.C6H11N5.C5H5N5/c1-19(41)44-18-23-22(8-9-32-28(23)39-12-11-38-25-7-5-4-6-20(25)15-26(38)30(39)43)21-14-24(29(42)37(3)16-21)33-31-34-27-17-36(2)10-13-40(27)35-31;1-11(2,3)18-10(17)13-9-12-8-7-15(4)5-6-16(8)14-9;1-11(2,3)17-10(16)13-9-12-8-6-4-5-7-15(8)14-9;1-10(2,3)17-9(16)13-8-12-7-6-11-4-5-15(7)14-8;1-2-14-8(13)12-7(15)11-6-5-9-3-4-10-6;1-10-2-3-11-5(4-10)8-6(7)9-11;6-5-8-4-3-7-1-2-10(4)9-5/h8-9,14-16H,4-7,10-13,17-18H2,1-3H3,(H,33,35);5-7H2,1-4H3,(H,13,14,17);4-7H2,1-3H3,(H,13,14,16);4-6H,1-3H3,(H,13,14,16);3-5H,2H2,1H3,(H2,10,11,12,13,15);2-4H2,1H3,(H2,7,9);1-3H,(H2,6,9)
InChIKeyBPNVHCTZEYZZTG-UHFFFAOYSA-N
XLogP7.07
TPSA560.35 Ų
H-Bond Donors8
H-Bond Acceptors44
Rotatable Bonds11
Heavy Atoms132
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001839.10
LogP ≤ 57.07
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1044

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze tert-butyl N-(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;tert-butyl N-(5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl)carbamate;tert-butyl N-([1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;ethyl N-(pyrazin-2-ylcarbamothioyl)carbamate;7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-amine;[4-[1-methyl-5-[(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)amino]-6-oxo-3-pyridinyl]-2-(1-oxo-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-2-yl)-3-pyridinyl]methyl acetate;[1,2,4]triazolo[1,5-a]pyrazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of tert-butyl N-(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;tert-butyl N-(5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl)carbamate;tert-butyl N-([1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;ethyl N-(pyrazin-2-ylcarbamothioyl)carbamate;7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-amine;[4-[1-methyl-5-[(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)amino]-6-oxo-3-pyridinyl]-2-(1-oxo-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-2-yl)-3-pyridinyl]methyl acetate;[1,2,4]triazolo[1,5-a]pyrazin-2-amine?
The IUPAC name of tert-butyl N-(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;tert-butyl N-(5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl)carbamate;tert-butyl N-([1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;ethyl N-(pyrazin-2-ylcarbamothioyl)carbamate;7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-amine;[4-[1-methyl-5-[(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)amino]-6-oxo-3-pyridinyl]-2-(1-oxo-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-2-yl)-3-pyridinyl]methyl acetate;[1,2,4]triazolo[1,5-a]pyrazin-2-amine (CID 157422233) is tert-butyl N-(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;tert-butyl N-(5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl)carbamate;tert-butyl N-([1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;ethyl N-(pyrazin-2-ylcarbamothioyl)carbamate;7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-amine;[4-[1-methyl-5-[(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)amino]-6-oxo-3-pyridinyl]-2-(1-oxo-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-2-yl)-3-pyridinyl]methyl acetate;[1,2,4]triazolo[1,5-a]pyrazin-2-amine.
What is the SMILES notation for tert-butyl N-(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;tert-butyl N-(5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl)carbamate;tert-butyl N-([1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;ethyl N-(pyrazin-2-ylcarbamothioyl)carbamate;7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-amine;[4-[1-methyl-5-[(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)amino]-6-oxo-3-pyridinyl]-2-(1-oxo-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-2-yl)-3-pyridinyl]methyl acetate;[1,2,4]triazolo[1,5-a]pyrazin-2-amine?
The canonical SMILES for tert-butyl N-(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;tert-butyl N-(5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl)carbamate;tert-butyl N-([1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;ethyl N-(pyrazin-2-ylcarbamothioyl)carbamate;7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-amine;[4-[1-methyl-5-[(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)amino]-6-oxo-3-pyridinyl]-2-(1-oxo-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-2-yl)-3-pyridinyl]methyl acetate;[1,2,4]triazolo[1,5-a]pyrazin-2-amine is CC(=O)OCc1c(-c2cc(Nc3nc4n(n3)CCN(C)C4)c(=O)n(C)c2)ccnc1N1CCn2c(cc3c2CCCC3)C1=O.CC(C)(C)OC(=O)Nc1nc2cnccn2n1.CC(C)(C)OC(=O)Nc1nc2n(n1)CCCC2.CCOC(=O)NC(=S)Nc1cnccn1.CN1CCn2nc(N)nc2C1.CN1CCn2nc(NC(=O)OC(C)(C)C)nc2C1.Nc1nc2cnccn2n1.
What is the InChIKey of tert-butyl N-(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;tert-butyl N-(5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl)carbamate;tert-butyl N-([1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;ethyl N-(pyrazin-2-ylcarbamothioyl)carbamate;7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-amine;[4-[1-methyl-5-[(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)amino]-6-oxo-3-pyridinyl]-2-(1-oxo-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-2-yl)-3-pyridinyl]methyl acetate;[1,2,4]triazolo[1,5-a]pyrazin-2-amine?
The InChIKey is BPNVHCTZEYZZTG-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H35N9O4.C11H19N5O2.C11H18N4O2.C10H13N5O2.C8H10N4O2S.C6H11N5.C5H5N5/c1-19(41)44-18-23-22(8-9-32-28(23)39-12-11-38-25-7-5-4-6-20(25)15-26(38)30(39)43)21-14-24(29(42)37(3)16-21)33-31-34-27-17-36(2)10-13-40(27)35-31;1-11(2,3)18-10(17)13-9-12-8-7-15(4)5-6-16(8)14-9;1-11(2,3)17-10(16)13-9-12-8-6-4-5-7-15(8)14-9;1-10(2,3)17-9(16)13-8-12-7-6-11-4-5-15(7)14-8;1-2-14-8(13)12-7(15)11-6-5-9-3-4-10-6;1-10-2-3-11-5(4-10)8-6(7)9-11;6-5-8-4-3-7-1-2-10(4)9-5/h8-9,14-16H,4-7,10-13,17-18H2,1-3H3,(H,33,35);5-7H2,1-4H3,(H,13,14,17);4-7H2,1-3H3,(H,13,14,16);4-6H,1-3H3,(H,13,14,16);3-5H,2H2,1H3,(H2,10,11,12,13,15);2-4H2,1H3,(H2,7,9);1-3H,(H2,6,9).
What are the key properties of tert-butyl N-(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;tert-butyl N-(5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl)carbamate;tert-butyl N-([1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;ethyl N-(pyrazin-2-ylcarbamothioyl)carbamate;7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-amine;[4-[1-methyl-5-[(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)amino]-6-oxo-3-pyridinyl]-2-(1-oxo-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-2-yl)-3-pyridinyl]methyl acetate;[1,2,4]triazolo[1,5-a]pyrazin-2-amine?
tert-butyl N-(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;tert-butyl N-(5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl)carbamate;tert-butyl N-([1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;ethyl N-(pyrazin-2-ylcarbamothioyl)carbamate;7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-amine;[4-[1-methyl-5-[(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)amino]-6-oxo-3-pyridinyl]-2-(1-oxo-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-2-yl)-3-pyridinyl]methyl acetate;[1,2,4]triazolo[1,5-a]pyrazin-2-amine has a molecular weight of 1839.10 g/mol, XLogP of 7.07, 11 rotatable bonds, 8 hydrogen bond donors, and 44 hydrogen bond acceptors.
Where does this data come from?
All data for tert-butyl N-(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;tert-butyl N-(5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl)carbamate;tert-butyl N-([1,2,4]triazolo[1,5-a]pyrazin-2-yl)carbamate;ethyl N-(pyrazin-2-ylcarbamothioyl)carbamate;7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-amine;[4-[1-methyl-5-[(7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)amino]-6-oxo-3-pyridinyl]-2-(1-oxo-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-2-yl)-3-pyridinyl]methyl acetate;[1,2,4]triazolo[1,5-a]pyrazin-2-amine is sourced from PubChem (CID 157422233), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).